跳至主要内容
临床试验/NCT05339113
NCT05339113Unknown不适用

Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

The National Center of Oncology, Azerbaijan2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年2月4日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Maximum standardised uptake value [SUVmax] for primary lesion

研究概览

简要总结

The aim of this study is to compare the diagnostic performance of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in primary and metastatic lesions of breast cancer and to reveal the best diagnostic imaging time of 68Ga-FAPI-46 PET/CT.

详细描述

Participants with breast carcinoma will undergo contemporaneous 18F-FDG and 68Ga-FAPI PET/CT. Tumor uptake will be quantified by the maximum standard uptake value (SUVmax). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 18F-FDG and 68Ga-FAPI PET/CT will be calculated and compared to evaluate the diagnostic efficacy. In addition, best diagnostic imaging time of 68Ga-FAPI-46 PET/CT will be evaluated at 10th, 30th and 60th minute scan time.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • adult participants (aged 18 years or order);
  • participants with newly diagnosed breast carcinoma;
  • pathology confirmed by lesion tru-cut biopsy;
  • participants who were able to provide informed consent.

排除标准

  • participants with non-malignant lesions;
  • participants with pregnancy;
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

结局指标

主要结局

Maximum standardised uptake value [SUVmax] for primary lesion

时间窗: 2-3 days

SUVmax of 68Ga-FAPI PET/CT for breast carcinoma in comparison with SUVmax value of 18F-FDG PET/CT

Best diagnostic imaging time of 68GaFAPI-46 PET/CT

时间窗: 2-3 days

Tumor-to-background ratio values measured over the 10th, 30th and 60th minute scan time

次要结局

  • SUVmax for metastatic lymph nodes(2 days)
  • Correlation between tumor SUVmax values and pathology grade(2 days)
  • Diagnostic efficacy for breast carcinomas(2 days)
  • Diagnostic efficacy for metastatic lymph nodes(2 days)

研究者

发起方
The National Center of Oncology, Azerbaijan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Fuad Novruzov

Head of Nuclear Medicine Department

The National Center of Oncology, Azerbaijan

研究点 (2)

Loading locations...

相似试验